Expression of nicotinamide N-methyltransferase in hepatocellular carcinoma is associated with poor prognosis.
Expression of nicotinamide N-methyltransferase in hepatocellular carcinoma is associated with poor prognosis.
复制标题
DOI:
10.1186/1756-9966-28-20
复制
发表时间:
2009-02-16
期刊:
影响因子:
--
通讯作者:
Kim DS
中科院分区:
文献类型:
--
作者:
Kim J;Hong SJ;Lim EK;Yu YS;Kim SW;Roh JH;Do IG;Joh JW;Kim DS
Hepatocellular carcinoma (HCC) is the most common tumor in the adult liver, with high relapse and mortality rates despite diverse treatment modalities. In this study, nicotinamide N-methyltransferase (NNMT), a key enzyme in drug metabolism, was investigated as a potential prognostic factor. Frozen tumors and non-cancerous surrounding tissues from 120 patients with primary HCC were studied. Expressions of NNMT and internal control genes were measured by real-time reverse-transcription PCR (RT-PCR). The relationship of NNMT mRNA level with clinicopathologic parameters and clinical outcome was evaluated. NNMT mRNA level is markedly reduced in HCCs compared to non-cancerous surrounding tissues (P < 0.0001), and NNMT expression in tumors was significantly correlated with tumor stage (P = 0.010). Moreover, stratification of patients based on tumor NNMT mRNA levels revealed that the patients who expressed higher NNMT mRNA levels tended to have a shorter overall survival (OS) time (P = 0.053) and a significantly shorter disease-free survival (DFS) time (P = 0.016). Both NNMT expression (P = 0.0096) and tumor stage (P = 0.0017) were found to be significant prognostic factors for DFS in a multivariate analysis. The results of this study indicated that NNMT gene expression is associated with tumor stage and DFS time in HCC cases. Because of the broad substrate specificity of NNMT, which could alter the efficacy and adverse effects of chemotherapy, NNMT merits further investigation regarding its role as a prognostic factor with a larger cohort of HCC patients.
登录
查看更多内容
DOI:
10.1093/jnen/61.2.111
发表时间:
2002-02-01
影响因子:
3.2
作者:
Parsons, RB;Smith, ML;Ramsden, DB
通讯作者:
Ramsden, DB
影响因子:
25.7
作者:
Llovet, JM;Beaugrand, M
通讯作者:
Beaugrand, M
DOI:
10.1056/nejmoa0804525
发表时间:
2008-11-06
期刊:
The New England journal of medicine
影响因子:
--
作者:
Hoshida Y;Villanueva A;Kobayashi M;Peix J;Chiang DY;Camargo A;Gupta S;Moore J;Wrobel MJ;Lerner J;Reich M;Chan JA;Glickman JN;Ikeda K;Hashimoto M;Watanabe G;Daidone MG;Roayaie S;Schwartz M;Thung S;Salvesen HB;Gabriel S;Mazzaferro V;Bruix J;Friedman SL;Kumada H;Llovet JM;Golub TR
通讯作者:
Golub TR
影响因子:
3.1
作者:
Jang, JS;Cho, HY;Kim, HW
通讯作者:
Kim, HW
DOI:
10.1111/j.1349-7006.1991.tb01793.x
发表时间:
1991-11-01
期刊:
JAPANESE JOURNAL OF CANCER RESEARCH
影响因子:
--
作者:
NAKAGAWA, K;MIYAZAKI, M;FUJIMURA, S
通讯作者:
FUJIMURA, S